Suchergebnisse - "Gendarme, Sébastien"

PubPharm (10)

1

Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer : A secondary analysis of ESOGIA-GFPC-GECP 08-02 study

enthalten in: Journal of geriatric oncology | 2023

von Gendarme, S. | Zebachi, S. | Corre, R. | +12

2

Pulmonary toxicity of mTOR inhibitors. Comparisons of two populations : Solid organ recipients and cancer patients

enthalten in: Therapie | 2023

von Gendarme, S. | Pastré, J. | Billaud, E. | +6

3

Risk factors for early mortality of lung cancer patients in France : A nationwide analysis

enthalten in: Cancer medicine | 2022

von Goussault, H. | Gendarme, S. | Assié, J. | +7

4

Cost-Effectiveness of an Organized Lung Cancer Screening Program for Asbestos-Exposed Subjects

enthalten in: Cancers | 2022

von Gendarme, S. | Pairon, J. | Andujar, P. | +10

5

ROS-1 Fusions in Non-Small-Cell Lung Cancer : Evidence to Date

enthalten in: Current oncology (Toronto, Ont.) | 2022

von Gendarme, S. | Bylicki, O. | Chouaid, C. | +1

6

Risk factors for early mortality of lung cancer patients in France : A nationwide analysis

enthalten in: Cancer Medicine | 2022

von Goussault, H. | Gendarme, S. | Assié, J. | +7

7

Factors associated with early lung cancer mortality : a systematic review

enthalten in: Expert review of anticancer therapy | 2021

von Goussault, H. | Gendarme, S. | Assié, J. | +2

8

Impact on All-Cause and Cardiovascular Mortality Rates of Coronary Artery Calcifications Detected during Organized, Low-Dose, Computed-Tomography Screening for Lung Cancer : Systematic Literature Review and Meta-Analysis

enthalten in: Cancers | 2021

von Gendarme, S. | Goussault, H. | Assié, J. | +3

9

Strong ALK and PD-L1 positive IHC expression related ALK amplification in an advanced lung sarcomatoid carcinoma : A therapeutic trap?

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2021

von Gendarme, S. | Matton, L. | Antoine, M. | +5

10

Monitoring Subsolid Pulmonary Nodules in High-Risk Patients Is Even More Cost-Effective When Combined With a Stop-Smoking Program

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2020

von Gendarme, S. | Chouaid, C.

CommentOn: J Thorac Oncol. 2020 Aug;15(8):1298-1305. - PMID 32171847

1
[1]